{"issuance_frequency":"","notes_translated":{"fr":"Santé Canada demande la participation des promoteurs au projet pilote non fonctionnel relatif au processus d'inscription réglementaire (PIR) pour les activités de réglementation liées aux essais cliniques. Le PIR est une méthode utilisée par Santé Canada pour recueillir des renseignements auprès des promoteurs sur leur entreprise, dossiers, activités réglementaires et transactions.","en":"Health Canada is requesting sponsor participation in the Regulatory Enrolment Process (REP) non-functional pilot for clinical trial regulatory activities. REP is a method Health Canada uses to collect information from sponsors related to their company, dossiers, products, regulatory activities and transactions."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"dbeb01aa-2574-40d0-8dd0-e3580aa8ac74","metadata_created":"2020-05-01T16:51:04.693242","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-05-01T16:51:04.693248","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2020-05-01","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["médicaments","processus d'inscription réglementaire (PIR)","essais cliniques"],"en":["Drug product","Regulatory Enrolment Process (REP)","clinical trial"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"Avis Mise à jour : Projet pilote non fonctionnel relatif au processus d’inscription réglementaire (PIR) pour les essais cliniques","en":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"dbeb01aa-2574-40d0-8dd0-e3580aa8ac74","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"02aafc93-34e7-4196-8d9c-e70461985071","related_relationship":"","name_translated":{"fr":"Avis Mise à jour : Projet pilote non fonctionnel relatif au processus d’inscription réglementaire (PIR) pour les essais cliniques","en":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials","language":["en"],"created":"2020-05-01T16:51:04.800863","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/regulatory-enrolment-process/updated-notice-non-functional-pilot-clinical-trials.html","last_modified":null,"position":0,"revision_id":"d9704816-c979-46b6-a3bd-46c5080ea92a","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"dbeb01aa-2574-40d0-8dd0-e3580aa8ac74","datastore_active":false,"character_set":"","related_type":"","state":"active","id":"a5689467-6dc0-4904-9ca5-822fb32963e3","related_relationship":"","name_translated":{"fr":"Avis Mise à jour : Projet pilote non fonctionnel relatif au processus d’inscription réglementaire (PIR) pour les essais cliniques","en":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials","language":["fr"],"created":"2020-05-01T16:51:04.800873","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/processus-inscription-reglementaire/avis-mise-a-jour-projet-pilote-non-fonctionnel-essais-cliniques.html","last_modified":null,"position":1,"revision_id":"d9704816-c979-46b6-a3bd-46c5080ea92a","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2020-04-22 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"dbeb01aa-2574-40d0-8dd0-e3580aa8ac74","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"Health Canada is requesting sponsor participation in the Regulatory Enrolment Process (REP) non-functional pilot for clinical trial regulatory activities. REP is a method Health Canada uses to collect information from sponsors related to their company, dossiers, products, regulatory activities and transactions.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Updated Notice: Regulatory Enrolment Process (REP) Non-Functional Pilot for Clinical Trials","revision_id":"d9704816-c979-46b6-a3bd-46c5080ea92a"}